Clinical Trial Update: Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

View source ↗

Summary

Clinical trial PROPHECY investigates patient-reported outcomes in Philadelphia-negative cytogenetic myeloproliferative neoplasms. The study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Myeloproliferative Neoplasm | Status: ACTIVE_NOT_RECRUITING